HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norbert F Voelkel Selected Research

benzyloxycarbonyl-asparagine (Z-Asp)

3/2006Beta-catenin in the fibroproliferative response to acute lung injury.
4/2002A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norbert F Voelkel Research Topics

Disease

44Pulmonary Hypertension
11/2020 - 04/2002
33Hypoxia (Hypoxemia)
01/2020 - 04/2002
26Emphysema
08/2014 - 05/2002
24Pulmonary Arterial Hypertension
01/2020 - 03/2007
18Inflammation (Inflammations)
10/2019 - 12/2004
14Vascular Remodeling
01/2020 - 05/2002
13Chronic Obstructive Pulmonary Disease (COPD)
10/2016 - 06/2003
12Heart Failure
09/2018 - 05/2002
10Hypertrophy
01/2020 - 04/2002
8Infections
01/2018 - 09/2003
6Vascular Diseases (Vascular Disease)
01/2020 - 08/2005
6Neoplasms (Cancer)
10/2017 - 12/2005
6Fibrosis (Cirrhosis)
02/2015 - 12/2007
6Acute Lung Injury
07/2012 - 05/2003
4Right Ventricular Hypertrophy
01/2016 - 08/2005
4Lung Injury
02/2012 - 03/2006
4Familial Primary Pulmonary Hypertension
05/2006 - 05/2002
3Cardiomegaly (Heart Hypertrophy)
01/2018 - 06/2013
3Systolic Heart Failure
04/2016 - 09/2010
3Left Ventricular Dysfunction
02/2015 - 01/2012
3Sepsis (Septicemia)
09/2014 - 06/2011
3Myocardial Infarction
03/2013 - 12/2011
3Microvascular Rarefaction
12/2011 - 09/2010
3Lung Diseases (Lung Disease)
08/2006 - 05/2002
2Vascular System Injuries
01/2021 - 06/2011
2Congenital Heart Defects (Congenital Heart Defect)
01/2020 - 01/2017
2Edema (Dropsy)
10/2017 - 05/2006
2Cardiotoxicity
06/2014 - 01/2013
2Transfusion-Related Acute Lung Injury
01/2014 - 05/2003
2Mitochondrial Diseases (Mitochondrial Disease)
06/2013 - 01/2013
2Hypothyroidism
01/2013 - 04/2012
2Right Ventricular Dysfunction
01/2013 - 05/2011
2Pneumonia (Pneumonitis)
11/2012 - 06/2011
2Body Weight (Weight, Body)
06/2011 - 01/2009
2Hypertension (High Blood Pressure)
02/2011 - 05/2006
2Obesity
09/2009 - 05/2006
2Virus Diseases (Viral Diseases)
09/2008 - 09/2003
2Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2007 - 07/2005

Drug/Important Bio-Agent (IBA)

24Semaxinib (SU5416)IBA
01/2021 - 04/2002
22Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020 - 05/2002
21Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 05/2002
17Proteins (Proteins, Gene)FDA Link
08/2014 - 05/2002
11SmokeIBA
10/2016 - 03/2005
7Pharmaceutical PreparationsIBA
01/2020 - 10/2012
7CytokinesIBA
01/2018 - 01/2007
6Biomarkers (Surrogate Marker)IBA
11/2020 - 03/2005
6MonocrotalineIBA
10/2019 - 12/2010
6AntioxidantsIBA
01/2015 - 04/2004
5Oxygen (Dioxygen)IBA
01/2021 - 03/2009
5CollagenIBA
01/2020 - 03/2006
5Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2015 - 12/2005
5Peptide Hydrolases (Proteases)FDA Link
02/2011 - 06/2003
4Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
10/2019 - 12/2004
4Leukotriene B4IBA
10/2017 - 05/2003
4Messenger RNA (mRNA)IBA
02/2015 - 05/2002
4ChemokinesIBA
07/2012 - 01/2007
4AntibodiesIBA
05/2012 - 04/2005
3Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2020 - 01/2015
3Estrogens (Estrogen)FDA Link
01/2019 - 09/2009
3Fatty Acids (Saturated Fatty Acids)IBA
09/2016 - 01/2013
3LipopolysaccharidesIBA
02/2015 - 08/2007
3InflammasomesIBA
02/2015 - 12/2011
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2014 - 06/2011
3Peroxidase (Myeloperoxidase)IBA
08/2014 - 01/2007
3Carvedilol (Coreg)FDA LinkGeneric
06/2014 - 09/2010
3Histone Deacetylases (Histone Deacetylase)IBA
06/2014 - 03/2011
3Oxidants (Oxidizing Agents)IBA
05/2013 - 03/2006
3EnzymesIBA
05/2013 - 05/2011
3Heme Oxygenase-1IBA
05/2013 - 04/2004
3Caspase 3 (Caspase-3)IBA
02/2012 - 04/2004
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2011 - 07/2007
3Biological ProductsIBA
05/2011 - 03/2005
3Viral ProteinsIBA
06/2009 - 08/2006
3prostacyclin synthetase (prostacyclin synthase)IBA
04/2007 - 12/2005
3Protease Inhibitors (Protease Inhibitor)IBA
06/2006 - 06/2003
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020 - 03/2003
2Morphine (MS Contin)FDA LinkGeneric
01/2020 - 06/2012
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2017 - 04/2007
2Lisinopril (Prinivil)FDA LinkGeneric
04/2016 - 10/2006
2Phosphotransferases (Kinase)IBA
03/2015 - 05/2002
2EicosanoidsIBA
01/2015 - 04/2007
2SolutionsIBA
09/2014 - 07/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
09/2014 - 09/2010
2Phenobarbital (Luminal)FDA Link
08/2014 - 01/2014
2trichostatin A (A 300)IBA
06/2014 - 03/2011
2Interleukin-1 (Interleukin 1)IBA
04/2014 - 01/2012
2Interleukin-6 (Interleukin 6)IBA
04/2014 - 11/2012
2IntegrinsIBA
01/2014 - 03/2006
2ProtandimIBA
05/2013 - 11/2009
2Thyroid HormonesIBA
01/2013 - 04/2012
2OvalbuminIBA
11/2012 - 10/2012
2MicroRNAs (MicroRNA)IBA
09/2012 - 03/2011
2Ion Channels (Ion Channel)IBA
07/2012 - 06/2009
2Dehydroascorbic AcidIBA
07/2012 - 06/2011
2CopperIBA
05/2012 - 01/2012
2theasinensin AIBA
05/2011 - 03/2011
2DNA (Deoxyribonucleic Acid)IBA
03/2009 - 09/2003
2ResistinIBA
01/2009 - 02/2008

Therapy/Procedure

19Therapeutics
01/2020 - 10/2002
3Subcutaneous Injections
08/2014 - 03/2007